We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Vernalis | LSE:VER | London | Ordinary Share | GB00B3Y5L754 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.17 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
22/4/2014 08:59 | Queen's Award for Enterprise- good for staff morale. | fhmktg | |
17/4/2014 19:26 | Annual report arrived today VERY professional presentation and good reading. Hang in there all you fellow British Biotech holders! Happy Easter | fhmktg | |
01/4/2014 12:43 | Hang in there. This is going places. | hvs | |
01/4/2014 12:41 | Just spotted a couple of buy notes for VER @ 43 & 51 on a link posted on another thread | q2u | |
01/4/2014 08:39 | quick read through suggests everything is more or less on track | meijiman | |
27/3/2014 08:12 | Another positive collaboration. Keep up the good work! | fhmktg | |
14/3/2014 14:46 | Hopefully the Government announcements to allow access to new drugs under an expedited process will help Vernalis with their oncology and pain control candidates. Some announcement of licence deal might be forthcoming in the near future. | fhmktg | |
27/2/2014 14:52 | still need 1.65 to break even not one of my brighter moves | 4screws | |
24/2/2014 13:12 | Could be around 2-3 years before we see the impact these cough formulations might have on Vernalis' profile and finances. Any comments on their significance? | fhmktg | |
18/2/2014 12:34 | That's 1.5 million bought today- wonder who is in the market? RNS please! | fhmktg | |
07/2/2014 21:59 | Relatively recent appointent of a new CEO with a positive and proactive policy, which we lacked for so long, is having a positive impact on the share price. I am a very long standing investor here and greatly encouraged by these events. Ref 1227 & 1228 | jarbie | |
07/2/2014 10:12 | Modest but sustained positive trading this morning- is there an update or tip out there which I have missed? | fhmktg | |
21/1/2014 12:01 | 100k bought this morning in single purchase. Interesting- somebody have some knowledge of impending news? | fhmktg | |
27/12/2013 11:22 | Important and potentially transforming year coming up IMHO | fhmktg | |
27/12/2013 10:50 | VERy quiet here for a share which has done + 100% in the last six months.... f | fillipe | |
04/12/2013 08:42 | it's certainly encouraging after all these years. I held from 2007 but exited when they carried on down after the consolidation. Been back in since July and not regretting it yet! | q2u | |
30/11/2013 18:10 | Do we finally have a Head with a Business Master Plan ? I hope so ! - a very long time holder | jarbie | |
28/11/2013 18:28 | This may be of interest to those holding here. | hastings | |
26/11/2013 12:26 | We have the start of very good performance for 2014. | hvs | |
01/10/2013 17:40 | Flurry of selling at the close! | fhmktg | |
01/10/2013 09:58 | Another small but useful income stream started with today's collaboration. | fhmktg | |
16/9/2013 08:53 | Our quintet of biotech picks includes the UK's leading player, £1.3 billion cap BTG (BTG), and three of its up-and-coming small quoted players in Vernalis (VER: AIM), owner of a unique portfolio of long-acting cough and cold treatments, novel therapeutic vaccine developer Scancell (SCLP) and diagnostics specialist Epistem (EHP: AIM). For our fifth pick we look to the US where companies have the best chance of raising the required funds to take a drug from the drawing board to market. Here we select Gilead Sciences (GILD:NDQ) which has developed a diversified pipeline of drugs including treatments for HIV/AIDS, hepatitis, respiratory and cardiovascular conditions and cancer. From Sharesmagazine. Google it to find | fhmktg | |
11/9/2013 10:34 | These shares are steaming ahead -Im not aware of any new developments but clearly some shrewd investors see the potential here. Think Glaxo might buy them at 55p-but its nice to dream. | meijiman | |
09/9/2013 19:22 | News tomorrow that they have been bought out by Glaxo at £5.50 a share........ (FFP, you are a dreamer.....ed) | ffp | |
09/9/2013 16:42 | why the rise all of a sudden, especially when so many AT Trades | 4screws |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions